Yingcheng Wu

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Topics

End Stage Renal Disease

Top Venues

International journal of cancer

Science (New York, N.Y.)

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Yingcheng Wu, Qiang Zou, Peng Jiang, Qiang Gao
Tumor-Host Cometabolism Collaborates to Shape Cancer Immunity. Cancer discovery 14 (4) (2024)
Jiaqiang Ma, Yingcheng Wu, Lifeng Ma, Xupeng Yang, Tiancheng Zhang, Qiang Gao, Teng Li, Ke Gao, Xia Shen, Jian Lin, Yamin Chen, Xiaoshan Liu, Yuting Fu, Xixi Gu, Zechuan Chen, Shan Jiang, Dong-Ning Rao, Jiaomeng Pan, Shu Zhang, Jian Zhou, Chen Huang, Xianjun Yu, Jia Fan, Guoji Guo, Xiaoming Zhang, Qiang Gao
A blueprint for tumor-infiltrating B cells across human cancers. Science (New York, N.Y.) 384 (6695) (2024)
Jiaqiang Ma, Yingcheng Wu, Lifeng Ma, Xupeng Yang, Tiancheng Zhang, Qiang Gao, Teng Li, Ke Gao, Xia Shen, Jian Lin, Yamin Chen, Xiaoshan Liu, Yuting Fu, Xixi Gu, Zechuan Chen, Shan Jiang, Dong-Ning Rao, Jiaomeng Pan, Shu Zhang, Jian Zhou, Chen Huang, Xianjun Yu, Jia Fan, Guoji Guo, Xiaoming Zhang, Qiang Gao
A blueprint for tumor-infiltrating B cells across human cancers. Science (New York, N.Y.) 384 (6695) (2024)
Shuyi Ji, Li Feng, Zile Fu, Gaohua Wu, Yingcheng Wu, Youpei Lin, Dayun Lu, Yuanli Song, Peng Cui, Zijian Yang, Chen Sang, Guohe Song, Shangli Cai, Yuanchuang Li, Hanqing Lin, Shu Zhang, Xiaoying Wang, Shuangjian Qiu, Xiaoming Zhang, Guoqiang Hua, Junqiang Li, Jian Zhou, Zhi Dai, Xiang-Dong Wang, Li Ding, Pei Wang, Daming Gao, Bing Zhang, Henry Rodriguez, Jia Fan, Hans Clevers, Hu Zhou, Yi-Di Sun, Qiang Gao
Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology. Science translational medicine 15 (706) (2023)
Mao Zhang, Yingying Huang, Jiaomeng Pan, Chen Sang, Youpei Lin, Liangqing Dong, Xia Shen, Yingcheng Wu, Qiang Gao, Shuyi Ji, Fen Liu, Mengcheng Wang, Yuyan Zheng, Sirui Zhang, Zefeng Wang, Jianke Ren, Daming Gao, Jian Zhou, Jia Fan, Wu Wei, Jian Lin, Qiang Gao
An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS mutant intrahepatic cholangiocarcinoma. Cancer discovery (2023)
Yingcheng Wu, Yifei Cheng, Xiang-Dong Wang, Jia Fan, Qiang Gao
Spatial omics: Navigating to the golden era of cancer research. Clinical and translational medicine 12 (1) (2022)
Yingcheng Wu, Yang Yang, Hongyan Gu, Baorui Tao, Erhao Zhang, Jinhuan Wei, Zhou Wang, Aifen Liu, Rong Sun, Miaomiao Chen, Yihui Fan, Renfang Mao
Multi-omics analysis reveals the functional transcription and potential translation of enhancers. International journal of cancer 147 (8) (2020)
Yingcheng Wu, Lifeng Lin, Yanting Shen, Huiqun Wu
Comparison between PD-1/PD-L1 inhibitors (nivolumab, pembrolizumab, and atezolizumab) in pretreated NSCLC patients: Evidence from a Bayesian network model. International journal of cancer 143 (11) (2018)
Yingcheng Wu, Qianqian Ju, Keren Jia, Jingyan Yu, Hui Shi, Huiqun Wu, Maorong Jiang
Correlation between sex and efficacy of immune checkpoint inhibitors (PD-1 and CTLA-4 inhibitors). International journal of cancer 143 (1) (2018)
Yingcheng Wu, Jinhuan Wei, Xia Chen, Yongwei Qin, Renfang Mao, Jian Song, Yihui Fan
Comprehensive transcriptome profiling in elderly cancer patients reveals aging-altered immune cells and immune checkpoints. International journal of cancer 144 (7) (2018)
Yingcheng Wu, Ran Xu, Keren Jia, Hui Shi
The efficacy of chimeric antigen receptor (CAR) immunotherapy in animal models for solid tumors: A systematic review and meta-analysis. PloS one 12 (11) (2017)
Yingcheng Wu, Hui Shi, Maorong Jiang, Mingyan Qiu, Keren Jia, Tianyue Cao, Yujuan Shang, Lili Shi, Kui Jiang, Huiqun Wu
The clinical value of combination of immune checkpoint inhibitors in cancer patients: A meta-analysis of efficacy and safety. International journal of cancer 141 (12) (2017)